Compounds for the treatment of inflammatory disorders
CA 2470620 A1 · Owner: Schering Corporation · Inventors: Mckittrick, Brian; Guo, Zhuyan; Sinning, Lisa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to compounds of the Formula (I):(Chemical formula should be inserted here as it appears on abstract in paper form)(I)or a pharmaceutically acceptable salt, solvate or isomer thereof which can be , useful for the treatment of diseases or conditions mediated by MMPs TNF-alpha , or combinations thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.